Related Experiment Video
Updated: Jun 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Parametric models for studying time to antiretroviral resistance associated with illicit drug use
Ajay K Sethi1, Stephen J Gange
1Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, 610 Walnut St, 587 WARF, Madison, WI 53726-2397, USA. aksethi@wisc.edu
Objective:
Biomedical researchers tend to choose semiparametric methods to model time-to-event data because they do not require any assumptions about the shape of the underlying hazard. An example is provided where parametric models are a desirable alternative.
Methods:
Data were analyzed from a prospective cohort study of 195 adults receiving HIV care and highly active antiretroviral therapy in Baltimore, Md. They were followed for 1188 visits between February 2000 and December 2001. Kaplan-Meier estimation and Cox and Weibull regressions were performed.
Results:
Illicit drug users experienced a greater hazard of clinically significant antiretroviral resistance as compared to non-users. Weibull regression demonstrated that a quarter and a half of illicit drug users developed resistance within 5 and 20 months of viral suppression, respectively, compared to 20 and 85 months, respectively, for non-users.
Conclusions:
Both semiparametric and parametric methods demonstrated an increased hazard of clinically significant resistance associated with illicit drug use. The parametric model facilitated the estimation of elapsed time to resistance associated with illicit drug use.
Related Concept Videos
Retrovirus Life Cycles
Analysis of Population Pharmacokinetic Data
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

